Stereotaxis (STXS) EBIT Growth (3y) (2013 - 2026)
Powered by 
Analysis
Stereotaxis (STXS) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 13.06% |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | -2.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2.10% |
| Dec 31, 2025 | -8.23% |
| Sep 30, 2025 | -9.08% |
| Jun 30, 2025 | 8.43% |
| Mar 31, 2025 | -13.18% |
| Dec 31, 2024 | -31.57% |
| Sep 30, 2024 | -11.16% |
| Jun 30, 2024 | -21.09% |
| Mar 31, 2024 | -45.90% |
| Dec 31, 2023 | -65.19% |
| Sep 30, 2023 | -53.37% |
| Jun 30, 2023 | -40.03% |
| Mar 31, 2023 | -39.89% |
| Dec 31, 2022 | -55.43% |
| Sep 30, 2022 | -396.78% |
| Jun 30, 2022 | -52.53% |
| Mar 31, 2022 | -24.10% |
| Dec 31, 2021 | -78.72% |
| Sep 30, 2021 | -243.71% |
| Jun 30, 2021 | -75.62% |